Shaji Kumar, MD, Mayo Clinic, Rochester, MN, describes the quality of life of patients undergoing CAR T-cell therapy vs. autologous and allogeneic stem cell transplant for hematologic malignancies. This interview took place at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.
